Innovation Pharmaceuticals Inc (IPIX)

[wsbc]

...Actually, ideal scenario would be to partner or sell following a P2.

To take the swing at a P3 for most small companies, unassisted, is far too capital-demanding.

Leo's maintained through the years that he's wanted to partner following P2's.

To-date this has never happened in any meaningful way.

We'll see what happens now.

The point of P2’s are to move to a P3.

LEO got a second chance at life with CV19.

Hopefully this time it hits